Profile data is unavailable for this security.
About the company
Chongqing Taiji Industry Group Co Ltd is a China-based company that is primarily engaged in the production and sale of Chinese and Western medicines. The company operates four segments. Pharmaceutical Industry segment mainly produces Chinese patent medicines and Western medicines. Pharmaceutical Business segment mainly includes pharmaceutical distribution and retail. The Company also operates Chinese herbal medicine resource segment and Service and Other segment. The Company's products include digestive system and metabolic drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, anti-infective drugs, nervous system drugs, anti-tumor and immune regulation drugs, and health products. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)10.04bn
- Net income in CNY-352.52m
- Incorporated1979
- Employees11.97k
- LocationChongqing Taiji Industry Group Co LtdNo.18Hengshan East Road, Yubei DistrictCHONGQING 401121ChinaCHN
- Phone+86 2 389886129
- Fax+86 2 389887399
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPC Pharmaceuticals Inc | 7.70bn | 530.05m | 9.46bn | 5.28k | 17.69 | 1.78 | -- | 1.23 | 0.7067 | 0.7067 | 10.21 | 7.01 | 0.6987 | 2.98 | 2.48 | 1,458,805.00 | 6.21 | 5.65 | 11.19 | 9.98 | 41.77 | 43.07 | 8.89 | 6.71 | 1.58 | -- | 0.1981 | 34.63 | -0.3408 | 0.6839 | 19.86 | 7.36 | -25.55 | 8.45 |
| North China Pharmaceutical Co Ltd | 9.79bn | 183.03m | 9.61bn | 10.09k | 52.59 | 1.75 | -- | 0.981 | 0.1065 | 0.1065 | 5.69 | 3.21 | 0.453 | 2.91 | 4.26 | 970,873.20 | 1.30 | -0.2469 | 3.23 | -0.578 | 30.05 | 33.78 | 2.86 | -0.5243 | 0.4902 | 2.22 | 0.6254 | -- | -2.48 | -2.94 | 2,496.80 | -5.90 | 3.21 | 0.00 |
| Shandong Lukang Pharmaceutical Co Ltd | 6.19bn | 188.75m | 9.66bn | 6.39k | 44.22 | 2.10 | -- | 1.56 | 0.2089 | 0.2089 | 6.85 | 4.40 | 0.6891 | 3.69 | 6.77 | 969,079.80 | 2.20 | 2.78 | 3.60 | 5.00 | 22.98 | 22.76 | 3.20 | 4.17 | 0.7984 | 6.01 | 0.4324 | 31.07 | 1.41 | 10.80 | 60.30 | 26.62 | -19.55 | 24.01 |
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 9.94bn | 470.00 | 154.43 | 10.37 | -- | 14.02 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Chongqing Taiji Industry Group Co Ltd | 10.04bn | -352.52m | 9.99bn | 11.97k | -- | 2.82 | -- | 0.9947 | -0.8238 | -0.8238 | 18.98 | 6.42 | 0.7032 | 2.85 | 3.55 | 838,688.20 | -2.36 | 0.9924 | -6.94 | 3.04 | 26.30 | 43.37 | -3.35 | 1.08 | 0.4906 | 0.5756 | 0.5914 | 22.39 | -20.72 | 1.24 | -96.76 | -- | -3.36 | -- |
| Youcare Pharmaceutical Group Co Ltd | 2.55bn | -233.99m | 10.21bn | 3.28k | -- | 2.98 | -- | 4.01 | -0.5306 | -0.5306 | 5.75 | 7.62 | 0.4537 | 2.18 | 4.03 | 777,123.10 | -4.30 | 5.90 | -5.97 | 8.92 | 47.55 | 63.64 | -9.48 | 7.49 | 1.49 | -41.24 | 0.1633 | 66.99 | -9.90 | -2.48 | -33.05 | -15.40 | 19.36 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 225.16m | -583.52m | 10.64bn | 743.00 | -- | 5.95 | -- | 47.24 | -1.59 | -1.59 | 0.6141 | 4.88 | 0.0712 | 0.3088 | 10.33 | 303,044.90 | -18.45 | -- | -19.95 | -- | 90.99 | -- | -259.16 | -- | 7.37 | -- | 0.3694 | -- | 2,384.11 | -- | 0.5049 | -- | -- | -- |
| Liaoning Chengda Biotechnology Co Ltd | 1.47bn | 177.94m | 10.81bn | 1.81k | 59.95 | 1.15 | -- | 7.36 | 0.433 | 0.433 | 3.56 | 22.54 | 0.1482 | 0.6786 | 1.24 | 813,192.10 | 1.79 | 8.07 | 1.86 | 8.36 | 79.03 | 84.98 | 12.11 | 35.75 | 19.28 | -- | 0.0013 | 44.77 | -4.22 | -0.0082 | -26.42 | -13.26 | -4.72 | -- |
Data as of Feb 10 2026. Currency figures normalised to Chongqing Taiji Industry Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Life Asset Management Co., Ltd.as of 31 Mar 2025 | 6.94m | 1.25% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 6.30m | 1.13% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 6.18m | 1.11% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 3.94m | 0.71% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 3.79m | 0.68% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.85m | 0.51% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.91m | 0.34% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 1.85m | 0.33% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.37m | 0.25% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2025 | 1.25m | 0.22% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
